Botuo Biotech\'s announcement on adjusting the purchase price of some of the underlying stocks reserved for the company\'s 2024 employee stock ownership plan due to the implementation of dividends
Botuo Biotech: 2024 Annual General Meeting of Shareholders Meeting Information
2024 Annual General Meeting of Shareholders Meeting Materials
2024 Report on the Performance of Supervisory Duties by the Board Audit Committee on Accounting Firms
Cathay Pacific Haitong Securities Co., Ltd. summary report on the initial public offering of shares and continued supervision and sponsorship of Hangzhou Botuo Biotechnology Co., Ltd. and its listing on the Science and Technology Innovation Board
Cathay Pacific Haitong Securities Co., Ltd.\'s 2024 Continuous Supervision and Follow-up Report on Hangzhou Botuo Biotechnology Co., Ltd.
On the implementation status of the 2024 “Improve Quality, Increase Efficiency, and Focus on Rewards” Action Plan and the 2025 “Improve Quality, Increase Efficiency, and Focus on Rewards” Action Plan
2024 Independent Director Debriefing Report (Ying Guoqing)
2024 Independent Director Debriefing Report (Wang Liang)
2024 Accounting Firm Performance Evaluation Report
Special opinions of the board of directors on the independence of independent directors
2024 Annual Report of the Audit Committee of the Board of Directors
2024 Internal Control Audit Report
2024 Internal Control Evaluation Report
2024 Independent Director Debriefing Report (Wang Wenming)
2024 Audit Report
Botuo Biotech\'s announcement on the use of some idle own funds for cash management
Botuo Biotech\'s announcement on applying for financing lines from financial institutions in 2025
2024 Audit Report on the Deposit and Use of Raised Funds
Special audit report on the summary table of non-operating capital occupation and other related fund transactions